£161.00

Congenital Neurotransmitter Disorders: A Clinical Approach

Price data checked 2 days ago

View at Amazon

Price History & Forecast

Last 89 days • 89 data points

Historical
Generating forecast...
£161.00 £152.95 £156.17 £159.39 £162.61 £165.83 £169.05 26 January 2026 17 February 2026 11 March 2026 02 April 2026 24 April 2026

Price Distribution

Price distribution over 89 days • 1 price levels

Days at Price
89 days 0 22 45 67 89 £161 Days at Price

Price Analysis

Most common price: £161 (89 days, 100.0%)

Price range: £161 - £161

Price levels: 1 different prices over 89 days

Description

Congenital neurotransmitter disorders are nowadays recognised as important causes of severe, progressive encephalopathies mostly of early onset. They are ultraorphan diseases and numerous experiences confirm again and again that diagnosis and treatment of patients is often almost regularly delayed for many years, if ever at all. Specific therapeutic approaches which can lead to excellent outcomes, especially if instituted early, are thereby withheld from patients and their families. The diagnosis of these disorders is almost exclusively based on clinical signs and symptoms leading to measurement of metabolites in CSF, specifically the quantitative determination of the neurotransmitters or their metabolites, that is the amino acids glutamate, glycine and GABA, the acidic metabolites of the biogenic monoamines, and tetrahydrobiopterin metabolites. Important relationships have emerged in disturbances of folate- and vitamin B6-metabolism. Whilst the majority of the identified disorders are due to inherited enzyme deficiencies, defects in transport of active compounds (transpotopathies) have been reported very recently. There is however still widespread uncertainty about when to perform specialised CSF investigations and what to investigate, and these services are unavailable in most countries. The main focus of this book is the clinical approach to these disorders. We wanted to provide as much detailed information and recommendations on therapy, monitoring and follow-up as possible and hope for quicker and improved therapy for affected individuals. A further growing awareness of these disorders is needed to allow increased and earlier diagnosis of patients. Neuropediatricians and neurologists must become more familiar with the broad clinical spectrum of monogenic neurometabolic diseases, the role and place of specialised CSF investigations, and the available therapeutic approaches. Hopefully this publication will play its part in and expedite this process.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
01 December 2014
Listed Since
05 September 2014

Barcode

No barcode data available

Similar Products You Might Like

Neurochemistry of Metabolic Diseases: Lysosomal Storage Diseases, Phenylketonuria, and Canavan Disease
95% match

Neurochemistry of Metabolic Diseases: Lysosomal Storage Diseases, Phenylketonuria, and Canavan Disease

£152.99 25 Jan 2026
Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
94% match

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

Academic Press

£90.29 28 Mar 2026
Wiley Chemical Biology of Neurodegeneration - Molecular Approach
94% match

Wiley Chemical Biology of Neurodegeneration - Molecular Approach

Wiley

£135.00 26 Feb 2026
The Glutamate/GABA-Glutamine Cycle: Amino Acid Neurotransmitter Homeostasis: 13 (Advances in Neurobiology, 13)
94% match

The Glutamate/GABA-Glutamine Cycle: Amino Acid Neurotransmitter Homeostasis: 13 (Advances in Neurobiology, 13)

Springer

£145.51 09 Mar 2026
Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward
94% match

Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward

£87.14 26 Feb 2026
Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
94% match

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases

Springer

£179.99 22 Jan 2026
Excitotoxicity in Neurological Diseases: New Therapeutic Challenge
94% match

Excitotoxicity in Neurological Diseases: New Therapeutic Challenge

Springer

£110.66 08 Jan 2026
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
94% match

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Humana

£104.04 27 Feb 2026
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
94% match

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Humana

£80.28 22 Feb 2026
The Glutamate/GABA-Glutamine Cycle: Amino Acid Neurotransmitter Homeostasis: 13 (Advances in Neurobiology, 13)
94% match

The Glutamate/GABA-Glutamine Cycle: Amino Acid Neurotransmitter Homeostasis: 13 (Advances in Neurobiology, 13)

Springer

£135.76 12 Dec 2025
Neurochemistry of Metabolic Diseases - Research Textbook
94% match

Neurochemistry of Metabolic Diseases - Research Textbook

£88.77 22 Apr 2026
Humana - The Metabotropic Glutamate Receptors Book
94% match

Humana - The Metabotropic Glutamate Receptors Book

Humana

£113.48 20 Apr 2026
Neurochemistry: Molecular and Cellular Clinical Applications
94% match

Neurochemistry: Molecular and Cellular Clinical Applications

£122.99 14 Apr 2026
Neurologic Disease: A Modern Pathophysiologic Approach to Diagnosis and Treatment
93% match

Neurologic Disease: A Modern Pathophysiologic Approach to Diagnosis and Treatment

Springer

£108.84 28 Feb 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
93% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£89.02 09 Mar 2026
Metabolic Encephalopathy
93% match

Metabolic Encephalopathy

Springer

£108.63 24 Apr 2026
Academic Press - Neurotherapeutics in the Era of Translational Medicine
93% match

Academic Press - Neurotherapeutics in the Era of Translational Medicine

Academic Press

£133.47 18 Apr 2026
Cerebellar Degenerations: Clinical Neurobiology: 2 (Foundations of Neurology)
93% match

Cerebellar Degenerations: Clinical Neurobiology: 2 (Foundations of Neurology)

Springer

£168.66 10 Mar 2026
Amines and Their Metabolites: 2 (Neuromethods, 2)
93% match

Amines and Their Metabolites: 2 (Neuromethods, 2)

Humana

£87.00 21 Feb 2026
Neurobiology of Mental Disorders
93% match

Neurobiology of Mental Disorders

£102.93 24 Feb 2026
Excitatory Amino Acids: Clinical Results with Antagonists
93% match

Excitatory Amino Acids: Clinical Results with Antagonists

Academic Press

£128.21 13 Jan 2026
Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)
93% match

Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)

Humana

£176.26 24 Apr 2026
Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)
93% match

Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)

Humana

£148.66 08 Mar 2026
Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders
93% match

Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders

Academic Press

£90.46 12 Jan 2026